Your browser doesn't support javascript.
loading
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.
Jonsdottir, Hulda R; Siegrist, Denise; Julien, Thomas; Padey, Blandine; Bouveret, Mendy; Terrier, Olivier; Pizzorno, Andres; Huang, Song; Samby, Kirandeep; Wells, Timothy N C; Boda, Bernadett; Rosa-Calatrava, Manuel; Engler, Olivier B; Constant, Samuel.
Afiliación
  • Jonsdottir HR; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland; Department of Rheumatology, Immunology, and Allergology, Inselspital University Hospital, Bern, Switzerland; Department of BioMedical Research, University of Bern, Bern, Switzerland. Electronic address: hulda-run.jonsdottir@b
  • Siegrist D; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
  • Julien T; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, 69008, Lyon, France; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.
  • Padey B; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.
  • Bouveret M; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Terrier O; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.
  • Pizzorno A; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Huang S; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Samby K; Medicines for Malaria Venture, Geneva, Switzerland.
  • Wells TNC; Medicines for Malaria Venture, Geneva, Switzerland.
  • Boda B; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Rosa-Calatrava M; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, 69008, Lyon, France; CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.
  • Engler OB; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
  • Constant S; Epithelix Sàrl, Plan-les-Ouates, Switzerland. Electronic address: samuel.constant@epithelix.com.
Biomed Pharmacother ; 150: 113058, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35658229
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article